159 related articles for article (PubMed ID: 26976348)
1. Identification and optimization of hydrazone-gallate derivatives as specific inhibitors of DNA methyltransferase 3A.
Erdmann A; Menon Y; Gros C; Masson V; Aussagues Y; Ausseil F; Novosad N; Schambel P; Baltas M; Arimondo PB
Future Med Chem; 2016; 8(4):373-80. PubMed ID: 26976348
[TBL] [Abstract][Full Text] [Related]
2. Rapid synthesis of new DNMT inhibitors derivatives of procainamide.
Halby L; Champion C; Sénamaud-Beaufort C; Ajjan S; Drujon T; Rajavelu A; Ceccaldi A; Jurkowska R; Lequin O; Nelson WG; Guy A; Jeltsch A; Guianvarc'h D; Ferroud C; Arimondo PB
Chembiochem; 2012 Jan; 13(1):157-65. PubMed ID: 22170584
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel 3-halo-3-nitroflavanones and their activities as DNA methyltransferase inhibitors in cancer cells.
Pechalrieu D; Dauzonne D; Arimondo PB; Lopez M
Eur J Med Chem; 2020 Jan; 186():111829. PubMed ID: 31757526
[TBL] [Abstract][Full Text] [Related]
4. Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screening.
Chen S; Wang Y; Zhou W; Li S; Peng J; Shi Z; Hu J; Liu YC; Ding H; Lin Y; Li L; Cheng S; Liu J; Lu T; Jiang H; Liu B; Zheng M; Luo C
J Med Chem; 2014 Nov; 57(21):9028-41. PubMed ID: 25333769
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel inhibitors of DNA methylation by screening of a chemical library.
Ceccaldi A; Rajavelu A; Ragozin S; Sénamaud-Beaufort C; Bashtrykov P; Testa N; Dali-Ali H; Maulay-Bailly C; Amand S; Guianvarc'h D; Jeltsch A; Arimondo PB
ACS Chem Biol; 2013 Mar; 8(3):543-8. PubMed ID: 23294304
[TBL] [Abstract][Full Text] [Related]
6. Effect of Withaferin-A, Withanone, and Caffeic Acid Phenethyl Ester on DNA Methyltransferases: Potential in Epigenetic Cancer Therapy.
Kumar V; Dhanjal JK; Sari AN; Khurana M; Kaul SC; Wadhwa R; Sundar D
Curr Top Med Chem; 2024; 24(4):379-391. PubMed ID: 37496252
[TBL] [Abstract][Full Text] [Related]
7. Structural optimization of non-nucleoside DNA methyltransferase inhibitor as anti-cancer agent.
Zhong B; Vatolin S; Idippily ND; Lama R; Alhadad LA; Reu FJ; Su B
Bioorg Med Chem Lett; 2016 Feb; 26(4):1272-5. PubMed ID: 26774653
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents.
Alam MS; Lee DU
Arch Pharm Res; 2016 Feb; 39(2):191-201. PubMed ID: 26694484
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors.
Şenkardeş S; Kaushik-Basu N; Durmaz İ; Manvar D; Basu A; Atalay R; Küçükgüzel ŞG
Eur J Med Chem; 2016 Jan; 108():301-308. PubMed ID: 26695731
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of some hydrazone derivatives as new anticandidal and anticancer agents.
Altıntop MD; Özdemir A; Turan-Zitouni G; Ilgın S; Atlı Ö; İşcan G; Kaplancıklı ZA
Eur J Med Chem; 2012 Dec; 58():299-307. PubMed ID: 23142671
[TBL] [Abstract][Full Text] [Related]
11. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.
Fang MZ; Wang Y; Ai N; Hou Z; Sun Y; Lu H; Welsh W; Yang CS
Cancer Res; 2003 Nov; 63(22):7563-70. PubMed ID: 14633667
[TBL] [Abstract][Full Text] [Related]
12. N-(1'-naphthyl)-3,4,5-trimethoxybenzohydrazide as microtubule destabilizer: Synthesis, cytotoxicity, inhibition of cell migration and in vivo activity against acute lymphoblastic leukemia.
Salum LB; Mascarello A; Canevarolo RR; Altei WF; Laranjeira AB; Neuenfeldt PD; Stumpf TR; Chiaradia-Delatorre LD; Vollmer LL; Daghestani HN; de Souza Melo CP; Silveira AB; Leal PC; Frederico MJ; do Nascimento LF; Santos AR; Andricopulo AD; Day BW; Yunes RA; Vogt A; Yunes JA; Nunes RJ
Eur J Med Chem; 2015; 96():504-18. PubMed ID: 25951294
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biochemical evaluation of δ(2)-isoxazoline derivatives as DNA methyltransferase 1 inhibitors.
Castellano S; Kuck D; Viviano M; Yoo J; López-Vallejo F; Conti P; Tamborini L; Pinto A; Medina-Franco JL; Sbardella G
J Med Chem; 2011 Nov; 54(21):7663-77. PubMed ID: 21958292
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel DNA methyltransferase 3A inhibitors via structure-based virtual screening and biological assays.
Shao Z; Xu P; Xu W; Li L; Liu S; Zhang R; Liu YC; Zhang C; Chen S; Luo C
Bioorg Med Chem Lett; 2017 Jan; 27(2):342-346. PubMed ID: 27899265
[TBL] [Abstract][Full Text] [Related]
15. Discovery of novel Thieno[2,3-d]pyrimidin-4-yl hydrazone-based cyclin-dependent kinase 4 inhibitors: synthesis, biological evaluation and structure-activity relationships.
Horiuchi T; Takeda Y; Haginoya N; Miyazaki M; Nagata M; Kitagawa M; Akahane K; Uoto K
Chem Pharm Bull (Tokyo); 2011; 59(8):991-1002. PubMed ID: 21804244
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant, cytotoxic activities, and structure-activity relationship of gallic acid-based indole derivatives.
Khaledi H; Alhadi AA; Yehye WA; Ali HM; Abdulla MA; Hassandarvish P
Arch Pharm (Weinheim); 2011 Nov; 344(11):703-9. PubMed ID: 21953995
[TBL] [Abstract][Full Text] [Related]
17. Constrained analogues of procaine as novel small molecule inhibitors of DNA methyltransferase-1.
Castellano S; Kuck D; Sala M; Novellino E; Lyko F; Sbardella G
J Med Chem; 2008 Apr; 51(7):2321-5. PubMed ID: 18345608
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of new non nucleoside inhibitors of DNMT3A.
Erdmann A; Menon Y; Gros C; Molinier N; Novosad N; Samson A; Gregoire JM; Long C; Ausseil F; Halby L; Arimondo PB
Bioorg Med Chem; 2015 Sep; 23(17):5946-53. PubMed ID: 26220519
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel ribavirin hydrazone derivatives and anti-proliferative activity against A549 lung cancer cells.
Liu WY; Li HY; Zhao BX; Shin DS; Lian S; Miao JY
Carbohydr Res; 2009 Jul; 344(11):1270-5. PubMed ID: 19527904
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells.
Zwergel C; Schnekenburger M; Sarno F; Battistelli C; Manara MC; Stazi G; Mazzone R; Fioravanti R; Gros C; Ausseil F; Florean C; Nebbioso A; Strippoli R; Ushijima T; Scotlandi K; Tripodi M; Arimondo PB; Altucci L; Diederich M; Mai A; Valente S
Clin Epigenetics; 2019 May; 11(1):68. PubMed ID: 31060628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
